Analytical and clinical performance of molecular assay used by the Brazilian public laboratory network to detect and discriminate Zika, Dengue and Chikungunya viruses in blood
Open Access
- 13 February 2021
- journal article
- research article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 25 (2) , 101542
Abstract
No abstract availableKeywords
Funding Information
- FIOCRUZ
This publication has 15 references indexed in Scilit:
- Zika Virus Emergence and Expansion: Lessons Learned from Dengue and Chikungunya May Not Provide All the AnswersThe American Journal of Tropical Medicine and Hygiene, 2016
- Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and chikungunya virus detectionJournal of Clinical Virology, 2016
- Zika virus infection—the next wave after dengue?Journal of the Formosan Medical Association, 2016
- The Zika outbreak of the 21st centuryJournal of Autoimmunity, 2016
- Prolonged detection of Zika virus RNA in urine samples during the ongoing Zika virus epidemic in BrazilJournal of Clinical Virology, 2016
- Evolving RNA Virus Pandemics: HIV, HCV, Ebola, Dengue, Chikunguya, and now Zika!2016
- External quality assessment studies for laboratory performance of molecular and serological diagnosis of Chikungunya virus infectionJournal of Clinical Virology, 2016
- Chikungunya: bending over the Americas and the rest of the worldThe Brazilian Journal of Infectious Diseases, 2015
- Zika virus: following the path of dengue and chikungunya?The Lancet, 2015
- Development of a Sensitive Real-Time Reverse Transcriptase PCR Assay with an Internal Control to Detect and Quantify Chikungunya VirusClinical Chemistry, 2007